Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of autologous adipose-derived mesenchymal stem cells for bilateral limbal stem cell deficiency-associated keratopathy
2010-024328-53Phase 2Completed
- Sponsor
- FIBHULP
- Start
- Dec 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in keratopathy, sponsored by FIBHULP. Primary endpoints: Feasibility and safety and Cumulative incidence of treatment-attributed adverse effects. Started Dec 2011; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
keratopathy
Beyond the preview
Go deeper on 2010-024328-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024328-53.